Back to Search Start Over

Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities.

Authors :
Lichtman MA
Sham R
Source :
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2023 Nov; Vol. 103, pp. 102778. Date of Electronic Publication: 2023 Jun 22.
Publication Year :
2023

Abstract

Nineteen reports of 41 cases of acquired red cell elliptocytosis associated with a chronic myeloid neoplasm are described. Although the majority of cases have an abnormality of the long arm of chromosome 20, del(q20), several cases do not. Moreover, in one case a specific qualitative abnormality of red cell protein band 4.1(4.1R) was reported; however, several subsequent cases could find no abnormality of a red cell membrane protein or found a different abnormality, usually quantitative. Thus, this striking red cell phenotypic feature, acquired elliptocytosis, seen in myelodysplastic syndrome and other chronic myeloproliferative diseases, closely simulating the red cell phenotype of hereditary elliptocytosis, has an unexplained genetic basis, presumably as the result of an acquired mutation(s) in some chronic myeloid neoplasms.<br />Competing Interests: Declaration of competing interest None for both Drs. Lichtman and Sham.<br /> (Copyright © 2023 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1096-0961
Volume :
103
Database :
MEDLINE
Journal :
Blood cells, molecules & diseases
Publication Type :
Academic Journal
Accession number :
37379758
Full Text :
https://doi.org/10.1016/j.bcmd.2023.102778